Michael Crimmins, MD
Neurocritical Care · Aventura, FLNPI 1689830564
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Penumbra, Inc. at 24.8% of the total. 2025 is the largest year on record at $2,634, more than ten times the $125 reported in 2021. Among neurocritical care clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $66.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$1K
- Microvention, Inc.$1K
- Medtronic$1K
- Vasorum USA Inc.$639
- Stryker$564
- Route 92 Medical, Inc.$409
- plus $649 from 7 others
What the payments were for
- Travel & lodging$1993%
- Food & beverage$5,84297%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 14 | $1,498 |
| Microvention, Inc. | 13 | $1,276 |
| Medtronic | 26 | $1,005 |
| Vasorum USA Inc. | 1 | $639 |
| Stryker | 19 | $564 |
| Route 92 Medical, Inc. | 1 | $409 |
| Imperative Care, Inc | 8 | $197 |
| AbbVie | 1 | $125 |
| Vertex | 1 | $122 |
| Johnson & Johnson | 2 | $94 |
| Globus Medical | 2 | $46 |
| Terumo Medical Corporation | 2 | $45 |
| Abbott | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CELT ACD$639
- Penumbra Coil 400$414
- STENT$350
- Benchmark$336
- WEB Aneurysm Embolization System$325
- Penumbra System$257
- Pipeline$256
- ERIC RETRIEVAL DEVICE$183
- SURPASS EVOLVE$135
- AXS VECTA 71$135
- TREVO$135
- RED 72$132
- POD$127
- BOTOX$125
- JOURNAVX$122
How this compares
$6,041 in reported general payments places this provider in the 90th percentile of 36 neurocritical care providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 17 | $8,542 |
Paid to pharmacies, not to this prescriber.
Other neurocritical care in Aventura
- Abhi PandhiMiami$16K
- Kristine O PhelanMiami$7K
- Fadar OtiteMiami$5K
- Mubashir PervezWeston$3K
- Katharina BuslGainesville$1K
- Ashley RogersJacksonville$1K
- Marc-Alain BabiPort St Lucie$812
- Bassel RaadOrlando$609
- Micah SyJacksonville$605
- Juan Ramos-CansecoWest Palm Beach$512
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.